RxDoctor Payments Data

Shannon Johnson

Psychiatry · Bedford, TXNPI 1326146960

Payments from drug & device makers

$9,258in general payments, 2019–2025

Across 575 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$1K
  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$796
  • Otsuka America Pharmaceutical, Inc.$703
  • Alkermes, Inc.$688
  • Bausch Health US, LLC$625
  • plus $4K from 27 others

What the payments were for

  • Food & beverage$9,20999%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,258 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide12$5,369
Ziprasidone Hcl31$1,387
Duloxetine Hcl38$1,366
Clonazepam87$994
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine41$975
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$836
Quetiapine Fumarate29$700
Aripiprazole15$523
Lamotrigine31$471
Bupropion XlBupropion Hcl12$454
Alprazolam106$418
Venlafaxine Hcl ErVenlafaxine Hcl13$391
Diazepam25$352
Buspirone Hcl22$314
Trazodone Hcl39$297

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$419$5,36912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Bedford

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →